Benlysta: now covered by RAMQ (Québec)

February 1, 2024 – Benlysta, a prescription drug used to treat adults with lupus as well as adults with lupus-related kidney inflammation (active lupus nephritis), has been included in the latest update of RAMQ’s list of medications published on February 1, 2024. RAMQ’s List of Medications is a regulatory list of the medications covered by Québec’s basic prescription drug insurance plan. Details can be found here: List of medications | Régie de l’assurance maladie du Québec (RAMQ) (gouv.qc.ca)

French: https://www.ramq.gouv.qc.ca/sites/default/files/documents/non_indexes/liste_med_2024-02-01_fr.pdf

English: https://www.ramq.gouv.qc.ca/sites/default/files/documents/non_indexes/liste_med_2024-02-01_en.pdf

Lupus Blog Articles:

Scientists say they have identified a root cause of lupus — one that could pave the way for new treatments

Read

Belimumab (Benlysta) Now Approved in Saskatchewan, Nova Scotia, and New Brunswick for Lupus Nephritis

Read

Megakaryocyte: a new player in systemic lupus erythematosus

Read